Mixed Topics
Daily News Podcast
FDA approves Zephyr valves for emphysema
High RA biologic level linked with more infections.
Daily News Podcast
Updated anthrax vaccine recommendations
Unanimous approval of recommendation for 2018-19.
Daily News Podcast
Medicare beneficiaries are dying differently
The new data about end of life care for Medicare beneficiaries are a result of large efforts
Daily News Podcast
Addiction: Veterans with pain, opioid use disorder
Many veterans with comorbid pain and opioid use disorder are not receiving medication-assisted treatment.
Conference Coverage
Adalimumab strikes out for aortic inflammation in psoriasis
ORLANDO – Ustekinumab shows promise, but “we are still not certain.”
Daily News Podcast
Opioids do more harm than good for musculoskeletal pain
There is little evidence of pain, but there is evidence of adverse events.
Daily News Podcast
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
The first major options for Dravet comes by way of a controversial source
Daily News Podcast
Patients going without as insulin prices skyrocket
Insulin prices have increased by 300%, and it’s impacting adherence.
Conference Coverage
JAK inhibitor therapy promising for refractory dermatomyositis
ORLANDO – A pilot study of tofacitinib for refractory dermatomyositis in adults is underway.
Daily News Podcast
Galectin-3: A post-MI prognostic biomarker for our times
New research suggests that it could be independent of other markers
Video
Canakinumab cut gout attacks in CANTOS
AMSTERDAM – Post hoc analysis of data collected from the CANTOS trial showed that interleukin-1 blockade with canakinumab halved the rate of gout...